|
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e
| Section VI. Drugs Affecting Gastrointestinal Function > |
Chapter 47. Pharmacotherapy of Inflammatory Bowel Disease
Sections: Pharmacotherapy of Inflammatory Bowel Disease: Introduction, Pathogenesis of Inflammatory Bowel Disease, Mesalamine (5-ASA)-Based Therapy, Glucocorticoids, Immunosuppressive Agents, Biological Therapies, Antibiotics and Probiotics, Supportive Therapy in Inflammatory Bowel Disease, Therapy of Inflammatory Bowel Disease during Pregnancy, Clinical Summary, Bibliography.
Topics Discussed: inflammatory bowel disease; pharmacotherapy of gastrointestinal disorders.
Excerpt:"Inflammatory bowel disease (IBD) is a spectrum of chronic, idiopathic, inflammatory intestinal conditions. IBD causes significant gastrointestinal (GI) symptoms that include diarrhea, abdominal pain, bleeding, anemia, and weight loss. IBD also is associated with a variety of extraintestinal manifestations, including arthritis, ankylosing spondylitis, sclerosing cholangitis, uveitis, iritis, pyoderma gangrenosum, and erythema nodosum...."
The content above is only an excerpt.
For full access, log into an existing user account below,
purchase an annual subscription, or
purchase a short-term subscription to the complete website.
|
|
|
|
Or
|
|
|
|